Artificial rupture of membranes versus repeat intra-vaginal prostaglandins for induction of labour: a randomised controlled trial

Phase 4

Completed

• Conditions: induction of labour; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12613000370707
• Lead Sponsor: Mater Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 250

Inclusion Criteria

All women with live singleton pregnancies greater than or equal to 37+0 weeks planning induction of labour using intravaginal Dinoprostone (PGE2) will be suitable for inclusion in this study

Exclusion Criteria

Fetus with major congenital abnormality
Multiple pregnancies
Intrauterine fetal death
Any contraindication to vaginal birth
Women <18 years
Inability to consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time from commencement of induction of labour until birth[Birth]

Secondary Outcome Measures

Name	Time	Method
Mode of birth[Birth];Proportion of births occurring during business hours” (0800-1700) [Birth];Use of epidural in labour[Birth];Need for antibiotics in labour[Birth];Admission to Special Care or Intensive Care Nurseries[Birth];Post-partum haemorrhage (= estimated blood loss >1000ml) [Birth];Duration of admission[Hospital discharge]